1. Home
  2. FLS vs ARWR Comparison

FLS vs ARWR Comparison

Compare FLS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLS

Flowserve Corporation

HOLD

Current Price

$76.38

Market Cap

9.6B

Sector

Industrials

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$85.67

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
ARWR
Founded
1790
2003
Country
United States
United States
Employees
16000
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.2B
IPO Year
2006
2009

Fundamental Metrics

Financial Performance
Metric
FLS
ARWR
Price
$76.38
$85.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
10
Target Price
$86.00
$83.40
AVG Volume (30 Days)
1.8M
2.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.04%
N/A
EPS Growth
23.36
99.80
EPS
1.41
N/A
Revenue
N/A
$16,142,321.00
Revenue This Year
$6.80
N/A
Revenue Next Year
$6.22
N/A
P/E Ratio
$53.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.71
$15.01
52 Week High
$92.41
$95.49

Technical Indicators

Market Signals
Indicator
FLS
ARWR
Relative Strength Index (RSI) 58.21 57.13
Support Level $69.50 $70.03
Resistance Level $77.41 $87.83
Average True Range (ATR) 2.85 3.75
MACD 0.85 0.79
Stochastic Oscillator 72.99 59.42

Price Performance

Historical Comparison
FLS
ARWR

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: